Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-18-001011

Executive Vice President R&D gave up 53,117 shares (to pay taxes)

  • Executive Vice President R&D acquired 116,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LEBEL FRANCOIS Executive Vice President R&D 2017-12-29 Grant or award +116,000 253,683 D
LEBEL FRANCOIS Executive Vice President R&D 2017-12-30 Shares withheld for taxes −31,450 $4.14 $130,203 222,233 D
LEBEL FRANCOIS Executive Vice President R&D 2017-12-31 Shares withheld for taxes −21,667 $4.14 $89,701 200,566 D
Loading xslF345X03/doc4.xml…